Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

Summary

This is an open label study to evaluate the safety and initial efficacy of intra-articular administration of Allocetra in patients with Psoriatic Arthritis (PsA).

Timeline

Start

2024-08-01

Primary completion

2025-10-20

Completion

2026-04-08

Outcome

Outcome not reported

Stopped: “reprioritization”

Drugs

Indications